Objective: To report two cases of perhexiline toxicity associated with selective serotonin re-uptake inhibitor (SSRI) treatment.
Clinical picture: Serum perhexiline concentrations progressively increased after a 69-year-old man was concurrently prescribed paroxetine for the treatment of depression. An 84-year-old woman was admitted to hospital with severe, symptomatic perhexiline toxicity associated with fluoxetine treatment.
Treatment: In both cases, perhexiline therapy was suspended and treatment with SSRIs was withdrawn.
Outcome: Serum perhexiline concentrations declined following the withdrawal of paroxetine in one case, but in the case of the second patient perhexiline concentrations were extremely slow to decrease, resulting in referral to a rehabilitative care unit for convalescence.
Conclusions: Serum perhexiline concentrations may be elevated during concurrent treatment with SSRIs, potentially resulting in severe toxicity.
NemeroffCBde VaneCLPollockBGNewer antidepressants and the cytochrome P450 system. American Journal of Psychiatry1996; 153:311–320.
2.
ColePLBeamerADMcGowanNPerhexiline maleate in refractory angina. Circulation1990; 81:1260–1270.
3.
HorowitzJDButtonIKWingLMHIs perhexiline essential for the optimal management of angina pectoris?Australian and New Zealand Journal of Medicine1995; 25:111–113.
4.
LaplaneDBousserMGPolyneuropathy during perhexiline maleate therapy. International Journal of Neurology1981; 15:293–300.
5.
RobertsRKCohnDSeneviratneB.Liver disease induced by perhexiline maleate. Medical Journal of Australia1981; 2:553–554.
6.
MandelcornMMurphyJColmanJ.Papilledema without peripheral neuropathy in a patient taking perhexiline maleate. Canadian Journal of Opthalmology1982; 17:173–175.
7.
HorowitzJDSiaSTMacDonaldPSGobleAJLouisWJPerhexiline maleate treatment for severe angina pectoris — correlation with pharmacokinetics. International Journal of Cardiology1986; 13:219–229.
8.
HarveyATPreskornSHInteractions of serotonin reuptake inhibitors with tricyclic antidepressants. Archives of General Psychiatry1995; 52:783–785.
9.
WalleyTPirmohamedMProudloveCMaxwellD.Interaction of metoprolol and fluoxetine. Lancet1993; 341:967–968.
10.
GreenblattDJPreskornSHCotreauMMHorstWDHarmatzJSFluoxetine impairs clearance of alprazolam but not of clonazepam. Clinical Pharmacology and Therapeutics1992; 52:479–486.
11.
GoffDCMidhaKKBrotmanAWWaitesMBaldessariniRJElevation of plasma concentrations of haloperidol after addition of fluoxetine. American Journal of Psychiatry1991; 148:790–792.
12.
CreweHKLennardMSTuckerGTWoodsFRHaddockREThe effect of selective serotonin reuptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology1992; 34:262–265.
